This Viewpoint discusses factors that play a role in the low rate of lipid screening in children, including a lack of compelling evidence, disagreement with recommendations, and concerns for overdiagnosis and overtreatment. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Errors in Supplement Clinical Practice Guidelines JAMA Pediatrics Clinical Practice Guidelines School Readiness Before and During the COVID-19 Pandemic Linking Health and School Data Clinical Practice Guidelines Error in Results Clinical Practice Guidelines Options for Detecting Risk of Aminoglycoside-Induced Ototoxicity in Neonates—Reply Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.